174 related articles for article (PubMed ID: 8491233)
41. Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina--value of washout rate analysis.
Sakata K; Yoshida H; Sugino H; Iimuro M; Matsunaga Y; Ono N; Morishima S; Hoshino T; Kaburagi T
Jpn Circ J; 1994 Jun; 58(6):379-88. PubMed ID: 8065009
[TBL] [Abstract][Full Text] [Related]
42. [Coronary flow reserve evaluated by 201Tl myocardial perfusion SPECT after coronary artery bypass grafting (CABG) for angina pectoris].
Ishino Y; Nakata H
Kaku Igaku; 2000 Nov; 37(6):621-9. PubMed ID: 11193447
[TBL] [Abstract][Full Text] [Related]
43. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
44. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty.
Yasuda T; Hashimura K; Matsu-ura Y; Kato Y; Ueda T; Mori I; Kijima Y
Jpn Circ J; 2001 Jun; 65(6):526-30. PubMed ID: 11407735
[TBL] [Abstract][Full Text] [Related]
45. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography.
Mahmarian JJ; Pratt CM; Cocanougher MK; Verani MS
Circulation; 1990 Oct; 82(4):1305-15. PubMed ID: 2401064
[TBL] [Abstract][Full Text] [Related]
46. Nicorandil for angina.
Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
[TBL] [Abstract][Full Text] [Related]
47. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi P; Chiariello M
Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
[No Abstract] [Full Text] [Related]
48. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
Purcell H; Fox K
Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
[TBL] [Abstract][Full Text] [Related]
49. Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris.
Barron HV; Sciammarella MG; Lenihan K; Michaels AD; Botvinick EH
Am J Cardiol; 2000 Jan; 85(1):1-7. PubMed ID: 11078227
[TBL] [Abstract][Full Text] [Related]
50. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris.
Meany TB; Richardson P; Camm AJ; Coltart J; Griffith M; Maltz MB; Signy M
Am J Cardiol; 1989 Jun; 63(21):66J-70J. PubMed ID: 2525329
[TBL] [Abstract][Full Text] [Related]
51. Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.
Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
Circ J; 2002 Apr; 66(4):317-22. PubMed ID: 11954943
[TBL] [Abstract][Full Text] [Related]
52. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
[No Abstract] [Full Text] [Related]
54. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.
Tsubokawa A; Ueda K; Sakamoto H; Iwase T; Tamaki S
Circ J; 2002 Dec; 66(12):1119-23. PubMed ID: 12499617
[TBL] [Abstract][Full Text] [Related]
55. Tl-201 myocardial perfusion SPECT: role of nitrate-augmented redistribution.
Wadhwa SS; Mansberg R; Fernandes VB
Clin Nucl Med; 1999 Jan; 24(1):1-5. PubMed ID: 9890484
[TBL] [Abstract][Full Text] [Related]
56. [Prophylactic effect of nicorandil on perioperative coronary spasm].
Hirose Y; Gamo M; Hirose M; Harigae M; Fujiwara C
Masui; 1998 Jun; 47(6):734-7. PubMed ID: 9691595
[TBL] [Abstract][Full Text] [Related]
57. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
[TBL] [Abstract][Full Text] [Related]
58. Effects of nicorandil and nifedipine on protection of ischemic myocardium.
Lamping KA; Christensen CW; Pelc LR; Warltier DC; Gross GJ
J Cardiovasc Pharmacol; 1984; 6(3):536-42. PubMed ID: 6202983
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of myocardial viability in the infarcted areas by the improved myocardial perfusion after percutaneous transluminal coronary angioplasty].
Yamazaki J; Ohsawa H; Igarashi M; Hosoi H; Morishita T; Nakano H; Yabe Y
J Cardiol; 1993; 23(3):241-8. PubMed ID: 8046588
[TBL] [Abstract][Full Text] [Related]
60. The role of nicorandil in the treatment of myocardial ischaemia.
Falase B; Easaw J; Youhana A
Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
